List of Kymab patents

Patents where

Current Assignee

Name

Kymab

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11297811 Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies	Patent 11297811 was granted and assigned to Kymab on April, 2022 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	11297811	April 12, 2022
‌ US Patent 10251377 Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies	Patent 10251377 was granted and assigned to Kymab on April, 2019 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	10251377	April 9, 2019
‌ US Patent 9567399 Antibodies and immunocytokines	Patent 9567399 was granted and assigned to Kymab on February, 2017 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9567399	February 14, 2017
‌ US Patent 11297810 Animal models and therapeutic molecules		Kymab	Kymab	United States Patent and Trademark Office	11297810	April 12, 2022
‌ US Patent 9957323 Anti-ICOS antibodies	Patent 9957323 was granted and assigned to Kymab on May, 2018 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9957323	May 1, 2018
‌ US Patent 11606941 Animal models and therapeutic molecules	Patent 11606941 was granted and assigned to Kymab on March, 2023 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	11606941	March 21, 2023
‌ US Patent 10226033 Animal models and therapeutic molecules	Patent 10226033 was granted and assigned to Kymab on March, 2019 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	10226033	March 12, 2019
‌ US Patent 9783593 Antibodies, variable domains and chains tailored for human use	Patent 9783593 was granted and assigned to Kymab on October, 2017 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9783593	October 10, 2017
‌ US Patent 9896516 Animal models and therapeutic molecules	Patent 9896516 was granted and assigned to Kymab on February, 2018 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9896516	February 20, 2018
‌ US Patent 10165763 Animal models and therapeutic molecules	Patent 10165763 was granted and assigned to Kymab on January, 2019 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	10165763	January 1, 2019
‌ US Patent 10064398 Animal models and therapeutic molecules	Patent 10064398 was granted and assigned to Kymab on September, 2018 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	10064398	September 4, 2018
‌ US Patent 9924705 Animal models and therapeutic molecules	Patent 9924705 was granted and assigned to Kymab on March, 2018 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9924705	March 27, 2018
‌ US Patent 9938357 Animal models and therapeutic molecules	Patent 9938357 was granted and assigned to Kymab on April, 2018 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9938357	April 10, 2018
‌ US Patent 11399522 Animal models and therapeutic molecules	Patent 11399522 was granted and assigned to Kymab on August, 2022 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	11399522	August 2, 2022
‌ US Patent 11564380 Animal models and therapeutic molecules		Kymab	Kymab	United States Patent and Trademark Office	11564380	January 31, 2023
‌ US Patent 9617338 Antibodies and immunocytokines	Patent 9617338 was granted and assigned to Kymab on April, 2017 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9617338	April 11, 2017
‌ US Patent 9253965 Animal models and therapeutic molecules	Patent 9253965 was granted and assigned to Kymab on February, 2016 by the United States Patent and Trademark Office.		Kymab	United States Patent and Trademark Office	9253965	February 9, 2016
‌ US Patent 9788534 Animal models and therapeutic molecules	Patent 9788534 was granted and assigned to Kymab on October, 2017 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9788534	October 17, 2017
‌ US Patent 9938358 Animal models and therapeutic molecules	Patent 9938358 was granted and assigned to Kymab on April, 2018 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9938358	April 10, 2018
‌ US Patent 11629189 Bispecific antibody for ICOS and PD-L1	Patent 11629189 was granted and assigned to Kymab on April, 2023 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	11629189	April 18, 2023
‌ US Patent 10149462 Animal models and therapeutic molecules	Patent 10149462 was granted and assigned to Kymab on December, 2018 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	10149462	December 11, 2018
‌ US Patent 9434782 Animal models and therapeutic molecules	Patent 9434782 was granted and assigned to Kymab on September, 2016 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9434782	September 6, 2016
‌ US Patent 11440960 TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo		Kymab	Kymab	United States Patent and Trademark Office	11440960	September 13, 2022
‌ US Patent 9505827 Animal models and therapeutic molecules	Patent 9505827 was granted and assigned to Kymab on November, 2016 by the United States Patent and Trademark Office.	Kymab	Kymab	United States Patent and Trademark Office	9505827	November 29, 2016
‌ US Patent 9445581 Animal models and therapeutic molecules	Patent 9445581 was granted and assigned to Kymab on September, 2016 by the United States Patent and Trademark Office.		Kymab	United States Patent and Trademark Office	9445581	September 20, 2016

Results per page:

96 results

0 selected

96 results

0 selected